论文部分内容阅读
目的探讨协同护理干预对慢性阻塞性肺疾病(COPD)患者预后及自我护理能力的影响。方法 114例COPD患者,随机分为观察组和对照组,各57例。对照组给于常规护理,观察组在对照组基础上给予协同护理干预。比较两组患者自我护理能力评分及肺功能指标。结果干预后观察组与对照组患者的自我护理能力评分均显著高于干预前,差异有统计学意义(t=25.325、6.640,P<0.01),且观察组患者自我护理能力评分(90.2±7.6)分高于对照组的(65.7±7.2)分,差异有统计学意义(t=17.668,P=0.000<0.01)。干预后观察组患者的最大肺活量(FVC)、第1秒用力呼气容积(FEV1)、第1秒用力呼气容积/用力肺活量比值(FEV1/FVC)指标均优于干预前,差异有统计学意义(t=7.769、7.550、7.006,P<0.01),且明显高于对照组,差异有统计学意义(P<0.01);干预后对照组患者FVC、FEV1、FEV1/FVC指标与干预前比较差异无统计学意义(t=1.688、1.295、0.783,P>0.05)。结论协同护理干预有利于提高COPD患者的自我护理能力,改善患者肺功能指标,有较高的临床推广价值。
Objective To investigate the effect of collaborative nursing intervention on the prognosis and self-care ability of patients with chronic obstructive pulmonary disease (COPD). Methods A total of 114 patients with COPD were randomly divided into observation group and control group, 57 cases each. The control group was given routine nursing care and the observation group was given the coordinated nursing intervention on the basis of the control group. The scores of self-care ability and indexes of pulmonary function were compared between the two groups. Results The scores of self-care ability of observation group and control group after intervention were significantly higher than those before intervention (t = 25.325, 6.640, P <0.01), and self-care ability score of observation group was 90.2 ± 7.6 ) Was higher than the control group (65.7 ± 7.2) points, the difference was statistically significant (t = 17.668, P = 0.000 <0.01). After intervention, the maximum vital capacity (FVC), FEV1, FEV1 / FVC in the observation group were better than before intervention, the difference was statistically significant (T = 7.769, 7.550, 7.006, P <0.01), and were significantly higher than those in the control group (P <0.01). The FVC, FEV1, FEV1 / FVC in the control group after intervention were significantly higher than those before the intervention The difference was not statistically significant (t = 1.688,1.295,0.783, P> 0.05). Conclusion Collaborative nursing intervention is beneficial to improve self-care ability of patients with COPD and to improve lung function indexes of patients with high clinical value.